Reports and Briefs on Respiratory in United Kingdom

Published within

« | 1 | 2 | » »|

Type Product title / description Pub Price
Report
Report

Epidemiology: COPD – Aging population and stable smoking rates to raise case numbers

Overview of chronic obstructive pulmonary disease, definition, and a review of epidemiology literature. The report provides in-depth analysis of patient populations, 10-year prevalent forecast, and key patient segments across the seven major markets.

Published By Datamonitor
17 Aug 2011 $2800
Buy
Report
Report

Prescribing Influences: Allergic Rhinitis – Treatment tolerability remains a key differentiator

In March 2011, Datamonitor surveyed 149 ENT and allergy specialists and pulmonologists in the seven major markets. The results are analyzed with key opinion leader interviews and secondary sources to assess allergic rhinitis prescribing influences.

Published By Datamonitor
25 Jul 2011 $2800
Buy
Report
Report

Product Profiles: Allergic Rhinitis - Heavily genericized market sees areas of innovation

Allergic rhinitis is an established, yet dynamic market. The April 2011 FDA filing of Dymista (azelastine/fluticasone; Meda/Cipla) could bring a new class to the market, while efforts to retain brand share have been seen in monotherapy classes.

Published By Datamonitor
23 Jun 2011 $6400
Buy
Report
Report

Epidemiology: Allergic Rhinitis - Allergic rhinitis is highly prevalent yet significantly under-diagnosed

Overview of allergic rhinitis definition and a review of the epidemiology literature. This report provides in-depth analysis of patient populations, a 10-year prevalent forecast, and key patient segments across the seven major markets.

Published By Datamonitor
05 Apr 2011 $2800
Buy
Report
Report

Forecast Insight: Asthma/COPD - Pipeline potential outweighs downward pressure from generics

Asthma and COPD market forecast for the seven major markets, incorporating the latest data from the European Respiratory Society 2010 Congress. Recent advances and setbacks of marketed/pipeline products and generics companies' actions are covered.

Published By Datamonitor
29 Sep 2010 $15200
Buy
Report
Report

Pipeline and Commercial Insight: Allergic Rhinitis - Immunotherapy growth surpassed by generic erosion

Overview of the current and future allergic rhinitis market, including in-depth analysis of changes in the market, 10 year indication specific sales forecasts of key classes, and a 10 year interactive patient based forecast for immunotherapy.

Published By Datamonitor
14 Jul 2010 $15200
Buy

« | 1 | 2 | » »|

No help is available.